New research reveals that people who stop using popular weight-loss injections like Mounjaro or Wegovy may regain lost weight much more quickly than those who stop conventional lifestyle programs.
Research printed in a leading medical journal demonstrates that while obese people often shed a large proportion of their body weight while undergoing treatment, the mass comes back at an estimated rate of nearly a kilo each month once they quit.
"People using these treatments must be aware of the potential of fast weight regain when the therapy ends," warns lead investigator Dr. Susan Jebb.
That rate of recovery means a return to starting mass within about 18 months.
Comparing Treatments
The analysis, which reviewed 37 of trials involving thousands of patients, contrasted the outcomes of GLP-1 agonists with conventional dieting.
Researchers note that individuals who lose weight through lifestyle changes alone typically experience a less rapid weight regain—around 0.1 kg a month—once they finish.
Understanding the Rapid Rebound
Experts propose the way of the jabs explains the heightened rebound.
The injections mimic a natural hormone called GLP-1, which controls hunger.
"Sustained high doses of GLP-1 concentrations far above than normal might result in the body to generate a reduced amount of its own natural GLP-1, and could reduce responsiveness to its effects," explained Dr. Adam Collins, a nutrition researcher.
"Discontinuation of this GLP-1 'fix' means appetite is unsuppressed, making overeating a significant risk."
An Ongoing Disease?
The NHS advise the injections for individuals with obesity-related medical conditions, alongside prescribed lifestyle changes.
Many experts argue that, due to the high risk of weight regain, the therapy is often long-term.
This opinion is reinforced by drug manufacturers, who say that the results "underscore the long-term character of excess weight," akin to managing diseases like hypertension.
Patient Accounts
People who have stopped the medication explain a sudden return of hunger.
"It was like a trigger that goes on and you're instantly ravenous," said an individual.
This difficulty is compounded if patients have not established sustainable lifestyle or habit modifications during treatment.
Significant Interest
Survey data suggest that a significant number of people in the UK have tried weight-loss jabs in the last 12 months, with desire being substantial.
- Use is more common among females than males.
- The 40s and 50s age group shows the greatest level of interest.
- Many access the drugs through private prescriptions rather than public health services.
Finally, researchers stress that while these medications are effective agents for shedding pounds, they are not a permanent cure and long-term success relies on ongoing lifestyle management.